[HTML][HTML] Optimization therapy for the treatment of chronic hepatitis B

EQ Chen, H Tang - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Chronic hepatitis B (CHB) is currently medically managed with either interferon-alpha or one
of the five nucleos (t) ide analogs. However, there are still a large number of CHB patients …

Chronic hepatitis B treatment eligibility and actual treatment rates in patients in community gastroenterology and primary care settings

VG Nguyen, K Wan, HN Trinh, J Li… - Journal of Clinical …, 2015 - journals.lww.com
Background: Guidelines have been devised to direct the care of patients with CHB but data
on the application of these guidelines, especially in primary care settings, has been limited …

[HTML][HTML] New globally faces of hepatitis B and C in the world

SM Alavian - Gastroenterology and Hepatology from Bed to Bench, 2011 - ncbi.nlm.nih.gov
1Worldwide, infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) have
become a major cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma (HCC) …

[HTML][HTML] Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha …

HB Fan, YB Guo, YF Zhu, AS Chen, MX Zhou… - Hepatitis …, 2012 - ncbi.nlm.nih.gov
Background: Hepatitis B virus (HBV) is one of leading causes of various hepatic diseases
including acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Hundreds of …

[HTML][HTML] Simultaneous detection of hepatitis B virus genotypes and mutations associated with resistance to lamivudine, adefovir, and telbivudine by the polymerase …

YZ Wang, JH Xiao, LG Liu, CY Ye, HY Shen… - Brazilian Journal of …, 2011 - SciELO Brasil
OBJECTIVES: Detection of mutations associated to nucleos (t) ide analogs and hepatitis B
virus (HBV) genotyping are essential for monitoring treatment of HBV infection. We …

[PDF][PDF] The S-gene mutations in the circulating HBV genotypes/sub-genotypes associated with hepatitis B infection in Uganda and their effects on cytokines expression …

KH Mukasa, K Abubaker, N Mariam, A Saad… - Section one …, 2021 - ijatsr.org
Hepatitis B virus is one of the major causes of chronic liver diseases, including
hepatocellular carcinoma. Liver damage as a result of HBV infection is due to host immune …

Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

E Guclu, N Tuna, O Karabay, S Akhan… - Journal of Infection in …, 2014 - avesis.mku.edu.tr
Introduction: Although pegylated interferons (pegIFNs) alpha-2a and alpha-2b have been
used in chronic hepatitis B (CHB) treatment for many years, there are few studies concerning …

Иммунотоксические эффекты интерферона.-2b, модифицированного иммобилизацией с помощью технологии электронно-лучевого синтеза

ДН Киншт, ПГ Мадонов, ЕЮ Шерстобоев… - Бюллетень …, 2017 - cyberleninka.ru
Цель исследования изучить иммунотоксическое действие лекарственного препарата
на основе интерферона.-2b, иммобилизированного на полиэтиленгликоле с помощью …

[HTML][HTML] Immunotoxic effects of interferon alpha-2b, modified by immobilization by means of electron-beam synthesis technology

DN Kinsht, PG Madonov, EY Sherstoboev… - Bulletin of Siberian …, 2018 - bulletin.ssmu.ru
The paper presents the results of investigation of immunotoxic action of interferon α-2b,
immobilized in polyethylene glycol by means of electron-beam synthesis technology …

Иммунотоксические эффекты интерферона альфа-2b, модифицированного иммобилизацией с помощью технологии электронно-лучевого синтеза

ДН Киншт, ПГ Мадонов, ЕЮ Шерстобоев… - … медицины. 2017. Т …, 2017 - 83.172.8.139
Цель исследования-изучить иммунотоксическое действие лекарственного препарата
на основе интерферона альфа-2b, иммобилизированного на полиэтиленгликоле с …